AXIOS December 12, 2024
Alison Snyder

President-elect Trump’s nominee to lead the National Institutes of Health has drawn scorn for his views on herd immunity and COVID, but Jay Bhattacharya’s arrival would put renewed focus on why a research institution with a nearly $48 billion budget doesn’t have more breakthroughs.

Why it matters: The controversial Stanford professor could rattle the scientific establishment and turf-conscious lawmakers in Congress, but also satisfy skeptics’ calls for a serious look under the hood at how NIH works.

  • There’s generally less risk-taking today that pushes science in new directions, in part because of economic incentives and the higher likelihood that research confirming earlier work will pay off.
  • “Getting science right is arguably the single-most important thing we can do in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies
PBM reform dropped in Congress' funding package
Trump's Picks for Top Health Jobs Not Just Team of Rivals but 'Team of Opponents'
Telehealth gets short extension, physician pay is cut in spending bill
From Book Burnings to Data Deletions: Safeguarding Health Info in the Digital Age
Congressional spending plan: What’s in it for healthcare, and what isn’t

Share This Article